The Aga Khan University (AKU) is a pioneering institution of higher education whose mission is to improve the quality of life in the developing world and beyond, through world-class teaching, research and healthcare delivery. AKU educates students for local and global leadership from campuses and teaching hospitals in six countries, primarily in Asia and Africa. It generates new knowledge to solve problems that affect millions of people, especially the most vulnerable. The University is a private, not-for-profit institution and part of the Aga Khan Development Network.
The Centre for Regenerative Medicine and Stem Cell Research (CRM) is one of the most ambitious and mission-critical initiatives at AKU. Established in 2016, in collaboration with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California San Francisco (UCSF), CRM is now part of the Medical College, based at the Aga Khan University campus in Pakistan. This integration with the larger research and clinical network of the University is anticipated to improve access to, and engagement with the Medical College’s broader intellectual network and multidisciplinary teams including clinicians, other basic scientists, and students. This will enable bridging stem cell and regenerative therapies in non-communicable and communicable diseases to patients by engaging closely with Aga Khan University Hospital and the Clinical Trials Unit at AKU.
The CRM is a pioneer in initiating research in regenerative medicine and stem cell biology in Pakistan with the mission to create a translational impact by attaining a deeper understanding of disease processes through functional basic science research enabling the development of novel therapies and translating these to bedside. Located on the first floor of the Juma Building, it consists of a wet-lab research space to accommodate 24-28 bench researchers. This Centre is ably supported by state-of the-art core facility including a Fluorescence-activated Cell Sorter (FACS), con-focal microscope, meta-system for chromosomal studies and a well-equipped tissue regeneration laboratory including a bio-printer. In addition, the CRM also boasts three independent tissue culture facilities dedicated for induced Pluripotent Stem Cells (iPSC), primary patient sampling and quarantine, and an established cancer cell line laboratory to support the ongoing research of CRM. In the future, a newly established and fully-equipped animal facility consisting of labs for conducting research on SCID, Nude and Transgenic mice along with a zebra fish containment laboratory will be constructed to further enhance research of CRM and the University.